neurodegenerative-diseases

Documents about neurodegenerative-diseases

• Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma#1486099ClinicalTrials.gov
• Ccf mtDNA as a Neurodegenerative Biomarker#969370ClinicalTrials.gov
• Randomized Control Trial of Small-Molecule Natural Flavonoids Intervention for Neurodegenerative Diseases#859094ClinicalTrials.gov
• Immunohistochemical Study of Neurodegenerative Diseases#858112ClinicalTrials.gov
• Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases#813652ClinicalTrials.gov
• Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases#1353187ClinicalTrials.gov
• The microbiota-proteostasis axis: implications in neurodegenerative diseases#1175063Europe PMC
• Clinical Study of [18F] PM-PBB3 PET Imaging of Tau Protein in Neurodegenerative Diseases#1421504ClinicalTrials.gov
• Electronic Nose for Diagnosis of Neurodegenerative Diseases Via Breath Samples#1438084ClinicalTrials.gov
• Clearance Mechanisms in Atypical Neurodegenerative Diseases#1421790ClinicalTrials.gov
• Blood biomarkers in neurodegenerative diseases: pre-analytical, analytical, and post-analytical challenges#254039HAL (France)
• Study of Neurodegenerative Diseases Induced Stem Cells in Patients and Healthy Family Controls.#872016ClinicalTrials.gov
• A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease#1086592ClinicalTrials.gov
• Retinal Neurodegenerative Signs in Alzheimer's Diseases#893208ClinicalTrials.gov
• Attitudes toward cannabidiol use among Bulgarian patients with neurodegenerative diseases and chronic pain#407476ARPHA OAI-PMH Endpoint
• Retinal Hyperspectral Imaging in Neurodegenerative Diseases#1454065ClinicalTrials.gov
• Phase separation and protein aggregation in neurodegenerative diseases#357342HAL (France)
• Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases#1294327ClinicalTrials.gov
• Improving mitochondria-associated endoplasmic reticulum membranes integrity as converging therapeutic strategy for rare neurodegenerative diseases and cancer#1120482HAL (France)
• AI-Based Differential Diagnosis of Neurodegenerative Diseases Using Structural MRI: A Systematic Review#1425887HAL (France)
• Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases#1452267ClinicalTrials.gov
• CLARA Testbed: HPCQC Infrastructure to Accelerate Research in Brain Science and Neurodegenerative Diseases#26405DataCite
• CLARA Testbed: HPCQC Infrastructure to Accelerate Research in Brain Science and Neurodegenerative Diseases#26406DataCite
• Speech and language characterization for neurodegenerative diseases detection#419380Spectrum: Concordia University Research Repository
• Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases#8060HAL (France)
• Saliva and Extracellular Vesicles for Neurodegenerative Diseases#874407ClinicalTrials.gov
• A framework of digital biomarkers for neurodegenerative diseases.#255395NCBI PubMed Central
• Citicoline Concentration in Human Vitreous#633779ClinicalTrials.gov
• HIFT in People With Parkinson's Disease#1213991ClinicalTrials.gov
• Blood And Tears in Alzheimer's Disease#1497590ClinicalTrials.gov
• Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.#1496004ClinicalTrials.gov
• Open-label Trial in Parkinson's Disease (PD)#1451493ClinicalTrials.gov
• Computerized Cognitive Training in Neurodegenerative Diseases (NDD2019)#845242ClinicalTrials.gov
• Cerebrospinal Fluid Repository#1430263ClinicalTrials.gov
• Dyskinesia in Parkinson's Disease (Study P04501)#825661ClinicalTrials.gov
• Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease#1059018ClinicalTrials.gov
• Normative Speech Modeling for ALS Diagnosis with Application to Other Neurodegenerative Diseases#310944bioRxiv / medRxiv
• Targeting mitochondria for the treatment of neurodegenerative diseases.#430890NCBI PubMed Central
• Dataset: network pharmacology, molecular docking and molecular dynamics analysis of pterostilbene targets in neurodegenerative diseases#206720RepOD Dataverse OAI Archive
• The locus coeruleus – norepinephrine system as a regulator of social perception#1208899PsyArXiv
• Database of Positon Emission Tomography (PET) Digital Brain Exams, in 50th Age of Patients#1161353ClinicalTrials.gov
• Neurodegenerative Diseases Progression Markers (MARKERS-NDD)#825305ClinicalTrials.gov
• Study in Parkinson's Disease of Exercise#1407448ClinicalTrials.gov
• Ambroxol to Slow Progression in Parkinson Disease#1281380ClinicalTrials.gov
• Research on RARs in neurodegenerative diseases: A bibliometric analysis.#323033NCBI PubMed Central
• Characterizing the heterogeneity of neurodegenerative diseases through EEG normative modeling#377998HAL (France)
• Neural plasticity during aging#1168880Repositorio institucional EdocUR
• The locus coeruleus – norepinephrine system as a regulator of social perception#637121PsyArXiv
• Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases#1184344ClinicalTrials.gov
• Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases#1465642ClinicalTrials.gov